JP2024520359A5 - - Google Patents

Info

Publication number
JP2024520359A5
JP2024520359A5 JP2023571902A JP2023571902A JP2024520359A5 JP 2024520359 A5 JP2024520359 A5 JP 2024520359A5 JP 2023571902 A JP2023571902 A JP 2023571902A JP 2023571902 A JP2023571902 A JP 2023571902A JP 2024520359 A5 JP2024520359 A5 JP 2024520359A5
Authority
JP
Japan
Prior art keywords
compound according
cycloalkyl
alkyl
optionally substituted
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023571902A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024520359A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/030690 external-priority patent/WO2022251188A2/en
Publication of JP2024520359A publication Critical patent/JP2024520359A/ja
Publication of JP2024520359A5 publication Critical patent/JP2024520359A5/ja
Pending legal-status Critical Current

Links

JP2023571902A 2021-05-25 2022-05-24 Alk2キナーゼのイミダゾール含有阻害剤 Pending JP2024520359A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163192822P 2021-05-25 2021-05-25
US63/192,822 2021-05-25
PCT/US2022/030690 WO2022251188A2 (en) 2021-05-25 2022-05-24 Imidazole-containing inhibitors of alk2 kinase

Publications (2)

Publication Number Publication Date
JP2024520359A JP2024520359A (ja) 2024-05-24
JP2024520359A5 true JP2024520359A5 (cg-RX-API-DMAC7.html) 2025-05-29

Family

ID=84230377

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023571902A Pending JP2024520359A (ja) 2021-05-25 2022-05-24 Alk2キナーゼのイミダゾール含有阻害剤

Country Status (23)

Country Link
US (1) US20240270750A1 (cg-RX-API-DMAC7.html)
EP (1) EP4346806A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024520359A (cg-RX-API-DMAC7.html)
KR (1) KR20240013145A (cg-RX-API-DMAC7.html)
CN (1) CN117529315A (cg-RX-API-DMAC7.html)
AR (1) AR125963A1 (cg-RX-API-DMAC7.html)
AU (1) AU2022283258A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023024537A2 (cg-RX-API-DMAC7.html)
CA (1) CA3219966A1 (cg-RX-API-DMAC7.html)
CL (1) CL2023003503A1 (cg-RX-API-DMAC7.html)
CO (1) CO2023017975A2 (cg-RX-API-DMAC7.html)
CR (1) CR20230597A (cg-RX-API-DMAC7.html)
DO (1) DOP2023000254A (cg-RX-API-DMAC7.html)
EC (1) ECSP23096182A (cg-RX-API-DMAC7.html)
GE (1) GEAP202416425A (cg-RX-API-DMAC7.html)
IL (1) IL308513A (cg-RX-API-DMAC7.html)
JO (1) JOP20230303A1 (cg-RX-API-DMAC7.html)
MX (1) MX2023013742A (cg-RX-API-DMAC7.html)
PE (1) PE20250022A1 (cg-RX-API-DMAC7.html)
PY (1) PY2240952A (cg-RX-API-DMAC7.html)
TW (1) TW202313625A (cg-RX-API-DMAC7.html)
UY (1) UY39788A (cg-RX-API-DMAC7.html)
WO (1) WO2022251188A2 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2022407047A1 (en) * 2021-12-08 2024-07-25 Kineta, Inc. Bicyclic heteroarenes and methods of their use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5405848A (en) * 1993-12-22 1995-04-11 Ortho Pharmaceutical Corporation Substituted thiazolylaminotetrahydropyridopyrimidines derivatives useful as platelet aggregation inhibitors
BR0111754A (pt) * 2000-06-28 2003-04-29 Astrazeneca Ab Uso de um composto, método para inibir aurora 2 quinase em um animal de sangue quente, composto, e, composição farmacêutica
US20070244114A1 (en) * 2004-07-06 2007-10-18 Myriad Genetics, Incorporated Compounds and therapeutical use thereof
JP2012504157A (ja) * 2008-09-30 2012-02-16 アストラゼネカ アクチボラグ 複素環式jakキナーゼ阻害剤
JP6121658B2 (ja) * 2011-06-29 2017-04-26 大塚製薬株式会社 治療用化合物、及び関連する使用の方法
CN108239071B (zh) * 2016-12-27 2020-12-04 沈阳药科大学 酰胺及硫代酰胺类衍生物及其制备方法和应用
AR112027A1 (es) * 2017-06-15 2019-09-11 Biocryst Pharm Inc Inhibidores de alk 2 quinasa que contienen imidazol
JP7659269B2 (ja) * 2018-12-21 2025-04-09 ユニバーシティ・オブ・ノートル・ダム・デュ・ラック 抗酸菌症治療のためのbdオキシダーゼ阻害剤の発見

Similar Documents

Publication Publication Date Title
JP2018158926A5 (cg-RX-API-DMAC7.html)
JP2007511504A5 (cg-RX-API-DMAC7.html)
ATE455119T1 (de) Thiazolo-, oxazalo und imidazolo- chinazolinverbindungen, die dazu fähig sind, proteinkinasen zu hemmen
JP2010511721A5 (cg-RX-API-DMAC7.html)
RU2010154172A (ru) Соединения для лечения рака
JP2021522166A5 (cg-RX-API-DMAC7.html)
JP2020523351A5 (cg-RX-API-DMAC7.html)
RU2018128318A (ru) Селективные ингибиторы эстрогеновых рецепторов и их применение
JP2020506951A5 (cg-RX-API-DMAC7.html)
JP2017526677A5 (cg-RX-API-DMAC7.html)
JP2009504764A5 (cg-RX-API-DMAC7.html)
JP2013531029A5 (cg-RX-API-DMAC7.html)
JP2011524422A5 (cg-RX-API-DMAC7.html)
JP2012508252A5 (cg-RX-API-DMAC7.html)
AR056327A1 (es) Compuestos de nucleosidos para el tratamiento de infecciones virales
JP2016503797A5 (cg-RX-API-DMAC7.html)
JP2022525069A5 (cg-RX-API-DMAC7.html)
JP2023513373A5 (cg-RX-API-DMAC7.html)
JP2022537140A5 (cg-RX-API-DMAC7.html)
JP2023101521A5 (cg-RX-API-DMAC7.html)
JP2006509842A5 (cg-RX-API-DMAC7.html)
JP2020502116A5 (cg-RX-API-DMAC7.html)
JP2011509302A5 (cg-RX-API-DMAC7.html)
JP2020111571A5 (cg-RX-API-DMAC7.html)
JP2024112835A5 (cg-RX-API-DMAC7.html)